A carregar...
Why miltefosine—a life-saving drug for leishmaniasis—is unavailable to people who need it the most
Miltefosine, the only oral drug approved for the treatment of leishmaniasis—a parasitic disease transmitted by sandflies—is considered as a success story of research and development (R&D) by a public-private partnership (PPP). It epitomises the multiple market failures faced by a neglected disea...
Na minha lista:
| Publicado no: | BMJ Glob Health |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5935166/ https://ncbi.nlm.nih.gov/pubmed/29736277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgh-2018-000709 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|